Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rouhi

Showing results (561-570 of 580) with videos related to

Pageof 58
Sort By:
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Journal of Cancer Survivorship : Research and Practice|August 8, 2025
Effectiveness of art interventions on improving psychological outcomes and quality of life among survivors of breast cancer: a systematic reviewAyush Patel, Shayan Raeisi Dehkordi, Shing Fung Lee, et al.
Leukemia|March 18, 2025
The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activationNadine Sperb, Irina A Maksakova, Leo Escano, et al.
Blood|March 31, 2021
Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemiaXiaojia Niu, Katharina Rothe, Min Chen, et al.
Journal of Clinical Immunology|September 1, 2005
Primary immune deficiencies presenting in adults: seven years of experience from IranDavood Mansouri, Parisa Adimi, Mehdi Mirsaedi, et al.
Blood Cell Therapy|September 10, 2025
Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 YearsSatarupa Mohapatra, Yasser R Abou Mourad, Hannah M Cherniawsky, et al.
Haematologica|December 9, 2017
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemiaEdith Schneider, Anna Staffas, Linda Röhner, et al.
British Journal of Haematology|July 25, 2022
Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysisJameel Abdulrehman, Carolyne Elbaz, David Aziz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid LeukemiaRaj Bhayadia, Kathrin Krowiorz, Nadine Haetscher, et al.
Experimental Hematology|July 13, 2015
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemiaBernhard Gentner, Nicole Pochert, Arefeh Rouhi, et al.
Pageof 58

Showing results (561-570 of 580) with videos related to

Sort By:
Pageof 58
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Journal of Cancer Survivorship : Research and Practice|August 8, 2025
Effectiveness of art interventions on improving psychological outcomes and quality of life among survivors of breast cancer: a systematic reviewAyush Patel, Shayan Raeisi Dehkordi, Shing Fung Lee, et al.
Leukemia|March 18, 2025
The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activationNadine Sperb, Irina A Maksakova, Leo Escano, et al.
Blood|March 31, 2021
Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemiaXiaojia Niu, Katharina Rothe, Min Chen, et al.
Journal of Clinical Immunology|September 1, 2005
Primary immune deficiencies presenting in adults: seven years of experience from IranDavood Mansouri, Parisa Adimi, Mehdi Mirsaedi, et al.
Blood Cell Therapy|September 10, 2025
Racial Disparity in Myeloablative Hematopoietic Cell Transplantation Outcomes in Patients with Hematological Malignancies Older Than 45 YearsSatarupa Mohapatra, Yasser R Abou Mourad, Hannah M Cherniawsky, et al.
Haematologica|December 9, 2017
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemiaEdith Schneider, Anna Staffas, Linda Röhner, et al.
British Journal of Haematology|July 25, 2022
Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysisJameel Abdulrehman, Carolyne Elbaz, David Aziz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid LeukemiaRaj Bhayadia, Kathrin Krowiorz, Nadine Haetscher, et al.
Experimental Hematology|July 13, 2015
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemiaBernhard Gentner, Nicole Pochert, Arefeh Rouhi, et al.
Pageof 58